Ritter Pharmaceuticals (RTTR) Reports Q2 Loss of $0.48/Share

Ritter Pharmaceuticals (NASDAQ: RTTR) reported Q2 EPS of ($0.48), versus ($4.18) reported last year.

For earnings history and earnings-related data on Ritter Pharmaceuticals (RTTR) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Deutsche Bank monitors UK auto sales as Chinese exports grow